AU1987692A - Method and composition for treating acne vulgaris containing a substantially anhydrous complex of pvp-h2o2 - Google Patents
Method and composition for treating acne vulgaris containing a substantially anhydrous complex of pvp-h2o2Info
- Publication number
- AU1987692A AU1987692A AU19876/92A AU1987692A AU1987692A AU 1987692 A AU1987692 A AU 1987692A AU 19876/92 A AU19876/92 A AU 19876/92A AU 1987692 A AU1987692 A AU 1987692A AU 1987692 A AU1987692 A AU 1987692A
- Authority
- AU
- Australia
- Prior art keywords
- pvp
- complex
- composition
- acne vulgaris
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010000496 acne Diseases 0.000 title claims description 24
- 239000000203 mixture Substances 0.000 title claims description 21
- 208000002874 Acne Vulgaris Diseases 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 8
- 239000000843 powder Substances 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000013011 aqueous formulation Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000005414 inactive ingredient Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 36
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 32
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 244000005714 skin microbiome Species 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 241001635598 Enicostema Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229960000913 crospovidone Drugs 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- -1 glycerol ester Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/702,546 US5122370A (en) | 1991-05-20 | 1991-05-20 | Method for treating acne vulgaris with a composition containing a stable, high purity, substantially anhydrous complex of PVP-H2 O.sub.2 |
| US702546 | 2010-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1987692A true AU1987692A (en) | 1992-12-30 |
Family
ID=24821662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU19876/92A Abandoned AU1987692A (en) | 1991-05-20 | 1992-04-01 | Method and composition for treating acne vulgaris containing a substantially anhydrous complex of pvp-h2o2 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5122370A (OSRAM) |
| EP (1) | EP0585345A1 (OSRAM) |
| AU (1) | AU1987692A (OSRAM) |
| CA (1) | CA2107673A1 (OSRAM) |
| WO (1) | WO1992020355A1 (OSRAM) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5130124A (en) * | 1991-05-01 | 1992-07-14 | Isp Investments Inc. | Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide |
| US5449519C1 (en) * | 1994-08-09 | 2001-05-01 | Revlon Consumer Prod Corp | Cosmetic compositions having keratolytic and anti-acne activity |
| US5985260A (en) * | 1995-09-18 | 1999-11-16 | Shanbrom Technologies, Llc | Disinfection of blood and biologicals with active albumin-iodine complex |
| US20050069502A1 (en) * | 2003-08-15 | 2005-03-31 | Chopra Suman K. | Hydrophobic polymer carrier based liquid tooth whitening composition |
| US8815215B2 (en) | 2003-08-15 | 2014-08-26 | Colgate-Palmolive Company | Hydrophobic tooth whitening system and methods of use |
| US20050036957A1 (en) * | 2003-08-15 | 2005-02-17 | Michael Prencipe | Tooth whitening dental tray and method of use |
| US20050036956A1 (en) * | 2003-08-15 | 2005-02-17 | Lin Fei | Non-aqueous liquid tooth whitening composition |
| US20050038181A1 (en) * | 2003-08-15 | 2005-02-17 | Colgate-Palmolive Company | Silicone polymer based liquid tooth whitening composition |
| EP1686919A1 (en) | 2003-10-14 | 2006-08-09 | Colgate-Palmolive Company | An applicator and method for applying a tooth whitening composition |
| US8137658B2 (en) | 2005-06-28 | 2012-03-20 | Isp Investments Inc. | Tooth whitening compositions |
| US20070071695A1 (en) | 2005-09-27 | 2007-03-29 | Colgate-Palmolive Company | Single phase whitening dentifrice |
| US20070071696A1 (en) * | 2005-09-27 | 2007-03-29 | Colgate-Palmolive Company | Dual phase whitening dentifrice |
| US20070183988A1 (en) * | 2006-02-03 | 2007-08-09 | GoSMILE, INC | Tooth whitening delivery system |
| US9682256B2 (en) * | 2006-07-14 | 2017-06-20 | Colgate-Palmolive Company | Methods of making compositions comprising films |
| FR2930725B1 (fr) * | 2008-04-30 | 2010-08-13 | Oreal | Compositions a base de complexes polymere-peroxyde d'hydrogene et leurs utilisations |
| BR112012015750A2 (pt) | 2009-12-23 | 2016-05-17 | Colgate Palmolive Co | composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental |
| BR112012021577A2 (pt) | 2010-03-11 | 2016-10-25 | Colgate Palmolive Co | composição de branqueamento dos dentes |
| WO2012047781A1 (en) | 2010-10-04 | 2012-04-12 | Church & Dwight Co., Inc. | Multi-purposed dentifrice |
| CN103260589A (zh) * | 2010-12-22 | 2013-08-21 | 高露洁-棕榄公司 | 口腔护理组合物 |
| MX352562B (es) | 2012-12-14 | 2017-11-28 | Colgate Palmolive Co | Métodos para blanquear los dientes. |
| CA2926396C (en) | 2013-12-05 | 2021-06-15 | Colgate-Palmolive Company | Oral care whitening compositions containing fatty amphiphiles |
| AU2016349500B2 (en) | 2015-11-05 | 2019-02-28 | Colgate-Palmolive Company | Durable dental film-forming composition and uses thereof |
| US10299998B2 (en) | 2015-11-20 | 2019-05-28 | Colgate-Palmolive Company | Single phase whitening dentifrice with high purity metaphosphate abrasive |
| WO2017105381A1 (en) | 2015-12-14 | 2017-06-22 | Colgate-Palmolive Company | Stable whitening oral care dentifrice compositions |
| EP3484437B1 (en) | 2016-08-11 | 2021-04-07 | Colgate-Palmolive Company | Dentifrice including zinc and blue dye or pigment |
| AU2016432061B2 (en) | 2016-12-06 | 2019-11-28 | Colgate-Palmolive Company | Oral care compositions and methods of use |
| US20180153781A1 (en) | 2016-12-06 | 2018-06-07 | Colgate-Palmolive Company | Oral Care Compositions and Methods of Use |
| CN110290777A (zh) | 2017-02-21 | 2019-09-27 | 高露洁-棕榄公司 | 口腔护理组合物和使用方法 |
| EP3716933A1 (en) | 2017-11-30 | 2020-10-07 | Colgate-Palmolive Company | Whitening compositions and methods for increasing stability of the same |
| AU2018375426C1 (en) | 2017-11-30 | 2022-02-03 | Colgate-Palmolive Company | Oral care compositions |
| WO2019108194A1 (en) | 2017-11-30 | 2019-06-06 | Colgate-Palmolive Company | Oral care compositions |
| CN111315345B (zh) | 2017-11-30 | 2023-06-16 | 高露洁-棕榄公司 | 口腔护理组合物和用于提高其稳定性的方法 |
| US11278478B2 (en) | 2017-12-13 | 2022-03-22 | Colgate-Palmolive Company | Oral care compositions and methods for increasing stability of the same |
| CN113226282A (zh) | 2018-12-26 | 2021-08-06 | 高露洁-棕榄公司 | 包括基于植物的磨料的口腔护理组合物及其方法 |
| WO2022032119A1 (en) | 2020-08-06 | 2022-02-10 | Colgate-Palmolive Company | Oral care composition comprising a specific preservative system |
| MX2023002272A (es) | 2020-09-02 | 2023-03-09 | Colgate Palmolive Co | Composiciones para el cuidado bucal. |
| CA3189823A1 (en) | 2020-09-02 | 2022-03-10 | Guisheng Pan | Oral care compositions |
| AU2021338260B2 (en) | 2020-09-02 | 2024-02-15 | Colgate-Palmolive Company | Oral care compositions |
| WO2022216666A1 (en) | 2021-04-08 | 2022-10-13 | Colgate-Palmolive Company | Oral care compositions |
| US20230057156A1 (en) | 2021-08-13 | 2023-02-23 | Colgate-Palmolive Company | Oral Care Compositions |
| EP4601605A1 (en) | 2022-11-22 | 2025-08-20 | Colgate-Palmolive Company | Oral care compositions |
| US20240173220A1 (en) | 2022-11-22 | 2024-05-30 | Colgate-Palmolive Company | Oral Care Compositions |
| AU2023385697A1 (en) | 2022-11-22 | 2025-05-22 | Colgate-Palmolive Company | Oral care compositions |
| AU2023408579A1 (en) | 2022-12-19 | 2025-06-26 | Colgate-Palmolive Company | Oral care compositions |
| EP4615407A1 (en) | 2022-12-19 | 2025-09-17 | Colgate-Palmolive Company | Oral care compositions |
| EP4637687A1 (en) | 2023-02-08 | 2025-10-29 | Colgate-Palmolive Company | Oral care compositions |
| WO2025006606A2 (en) | 2023-06-28 | 2025-01-02 | Colgate-Palmolive Company | Oral care compositions |
| WO2025031754A1 (en) | 2023-08-10 | 2025-02-13 | Unilever Ip Holdings B.V. | Oral care composition |
| WO2025072923A1 (en) | 2023-09-29 | 2025-04-03 | Colgate-Palmolive Company | Methods for reducing, alleviating, or treating gum disease |
| WO2025137235A2 (en) | 2023-12-20 | 2025-06-26 | Colgate-Palmolive Company | Oral care compositions |
| WO2025174942A1 (en) | 2024-02-16 | 2025-08-21 | Colgate-Palmolive Company | Methods for mediating an inflammatory response |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3376110A (en) * | 1967-01-30 | 1968-04-02 | Gen Aniline & Film Corp | Solid stabilized hydrogen peroxide compositions |
| US3480557A (en) * | 1967-01-30 | 1969-11-25 | Gaf Corp | Solid stabilized hydrogen peroxide compositions |
| US4163800A (en) * | 1977-08-17 | 1979-08-07 | The Procter & Gamble Company | Topical composition and treatment of skin lesions therewith |
| US4485091A (en) * | 1980-07-15 | 1984-11-27 | Quinoderm Limited | Dermatological compositions |
| LU85789A1 (fr) * | 1985-02-26 | 1986-09-02 | Oreal | Utilisation dans les domaines therapeutique et cosmetique d'une solution anhydre de peroxyde d'hydrogene |
| US5008106A (en) * | 1989-12-14 | 1991-04-16 | Gaf Chemicals Corporation | Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2 |
-
1991
- 1991-05-20 US US07/702,546 patent/US5122370A/en not_active Expired - Lifetime
-
1992
- 1992-04-01 EP EP92911927A patent/EP0585345A1/en not_active Ceased
- 1992-04-01 CA CA002107673A patent/CA2107673A1/en not_active Abandoned
- 1992-04-01 AU AU19876/92A patent/AU1987692A/en not_active Abandoned
- 1992-04-01 WO PCT/US1992/002542 patent/WO1992020355A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US5122370A (en) | 1992-06-16 |
| EP0585345A1 (en) | 1994-03-09 |
| EP0585345A4 (OSRAM) | 1994-04-06 |
| CA2107673A1 (en) | 1992-11-21 |
| WO1992020355A1 (en) | 1992-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5122370A (en) | Method for treating acne vulgaris with a composition containing a stable, high purity, substantially anhydrous complex of PVP-H2 O.sub.2 | |
| US5008106A (en) | Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2 | |
| US5183901A (en) | Urea-hydrogen peroxide-polyvinylpyrrolidone | |
| EP0221176B1 (en) | Pharmaceutical vehicles for recucing transdermal flux | |
| JP3583166B2 (ja) | 損傷皮膚修復用粉末製剤 | |
| US3761590A (en) | Silver sulfadiazine used in the treatment of burns | |
| US3671545A (en) | Polyvinylpyrrolidone-iodine compounds | |
| JPS59134726A (ja) | 低誘電溶媒を含有する貯蔵安定な局所薬剤組成物 | |
| IE61616B1 (en) | Pharmaceutical compositions | |
| JPS5837284B2 (ja) | セイヤクソセイブツノセイホウ | |
| US5206385A (en) | Urea-hydrogen peroxide-polyvinylpyrrolidone process | |
| CN100396287C (zh) | 含有电子转移剂磷酸盐衍生物的制剂 | |
| WO1991007184A1 (en) | SUBSTANTIALLY ANHYDROUS COMPLEXES OF PVP and H2O¿2? | |
| US3518344A (en) | Tableting lubricant | |
| CN1197552C (zh) | 应用抗炎剂的制剂 | |
| CN109602914B (zh) | 维生素b2修饰的铁基纳米酶及其制备方法和应用 | |
| JP2003518140A (ja) | 新規なポリエトキシル化ひまし油、その製造プロセスおよびその処方物 | |
| JPH10502355A (ja) | Ｎ−アセチル−ｌ−システインを含んだ局所組成物 | |
| US5846564A (en) | Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection | |
| JP3293643B2 (ja) | 発泡性成分及びその製造方法 | |
| EP0448288B1 (en) | Pharmaceutical iodine compositions | |
| JPH04288017A (ja) | にきび用化粧料 | |
| JPH02134322A (ja) | 放射線耐容性ヨウ素製剤 | |
| US3734734A (en) | Deproteinizing protein-containing solutions | |
| EP0773783B1 (en) | Preparation of fusidic acid tablets |